Event Information

Time: December 12~13, 2012

Venue: Sofitel, ChengDu
(No. 15, Binjiang Zhong Road, Chengdu, China)

Current Status of Cross-strait Cooperation/ Ms. Chao-Yi Wang, Vice Section Chief of Food and Drug Administration, Taiwan

Current Status of Pre-clinical Trail in China/ Mr. Wei Zhang, Director of Drug Registration Department State Food and Drug Administration, China

Researchers and Industrys Expectation on Cross-strait Cooperation/ Dr. Hongjen Chang, Vice Chairman of TRPMA

Taiwan New Drug R&D Case Sharing/ Dr. Ming-Chu Hsu, Chairman & CEO of TaiGen Biotechnology

Taiwan New Drug R&D Case Sharing/ Dr. Stanley Chang, Chairman & CEO of Medigen Biotechnology

Taiwan New Drug R&D Case Sharing/ Mr. George Yeh, President of Taiwan Liposome

Taiwan New Drug R&D Case Sharing/ Ms. Amy Huang, Chief Operating Officer of OBI Pharma

Taiwan New Drug R&D Case Sharing/ Dr. Ya-Chun Wang, Executive Vice President & Chief Scientific Officer of TCM Biotech

Summary & Future Prospect/ Moderator: Dr.Yiming Cui, Peking University Hospital; Dr. Hongjen Chang, Vice Chairman of TRPMA